Category: Patent Policy
-
Make SEPs Great Again: after President’s memo on 6G, USPTO forms SEP Working Group “to renew American leadership in technology standards”
With President Trump’s 6G memo before and the USPTO’s SEP Working Group announcement after Christmas, standards and the related patents get unprecedented political attention.
-
Quantum-related patents increased fivefold in past decade, but high barriers to adoption: OECD-EPO report
While the number of international patent family applications has surged fivefold since 2014, 80% of companies in the sector do not have quantum as their main activity, and Europe faces notable challenges in commercializing its technology.
-
Teva removes more than 200 patents from U.S. FDA’s Orange Book: win for FTC
Following President Trump’s promise to lower the cost of drugs and a United States Federal Trade Commission investigation into a patent portfolio owned by Teva, the Israeli pharma company has asked the Food and Drug Administration to remove more than 200 improper patent listings related to asthma, diabetes, and COPD drugs, and epinephrine autoinjectors, from…
-
Encourage FRAND SEP licensing negotiations through patent pools, intermediaries: The World Bank recommends to low, middle-income nations
The World Bank’s first-ever report on standards has issued several recommendations to low and middle-income nations on how they can leverage standard-essential patents to propel their economies, pointing to China and the Republic of Korea as model examples.
-
UK consultation on SEP legislation closed two months ago, and they can already scrap their plans because of what has happened since
The UK government gave stakeholders 12 weeks to comment on its vision of global FRAND resolution, but the following month the landscape changed.
-
USPTO Director Squires encourages fairer, more consistent patent eligibility in latest memoranda
USPTO Director John A. Squires reminds applicants and examiners that when used properly, Subject-Matter Eligibility Declarations can be effective, encouraging examiners not to reject patent applications too broadly.
-
USPTO Director Squires continues pro-patent enforcement march: IPR petition institutions remain low, submits first-ever public ITC comments
The United States Patent and Trademark Office’s low institution rate, together with its first-ever public comments to a United States International Trade Commission (ITC) investigation endorsing the ITC as a forum for adjudicating patents, underline Director John A. Squires’s pro-patent and pro-patent enforcement agenda.
-
Apple/Google/Amazon lobbying front takes astroturfing to new level of deception in EU Transparency Register and on its website
ACT | The App Association claims to represent thousands of small app makers, but 100% of its funding comes from large tech companies, particularly Apple, Google, and Amazon.
-
Podcast: interview with Dr. Bowman Heiden on role of SEPs in economics, policy intervention, cultivating a transatlantic IP career
Dr. Bowman Heiden is the Executive Director of the Tusher Strategic Initiative for Technology Leadership at UC-Berkeley. He is also the Co-Director of the Center for Intellectual Property (CIP) at the University of Gothenburg, and co-chair of the Technology, Innovation, and Intellectual Property program at the Classical Liberal Institute at the NYU School of Law. …
-
The Trump Administration is not above the law — but neither is Harvard: patent march-in rights
Whatever allegations the Trump Administration makes against Harvard and its affiliates may ultimately have to be discussed in court. But Harvard’s compliance is not beyond doubt.